Koninklijke Philips (PHG) Non-Current Deferred Tax Liability (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Non-Current Deferred Tax Liability came in at $106.5 million in Q1 2026, up 28.21% year-on-year from $83.1 million in Q1 2025, and down 1.59% quarter-over-quarter from $108.3 million in Q4 2025.
Koninklijke Philips (PHG) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Koninklijke Philips' Non-Current Deferred Tax Liability history runs 18 years deep, the most recent figure standing at $106.5 million for Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 28.21% year-over-year to $106.5 million in Q1 2026; TTM through Mar 2026 was $106.5 million, a 28.21% increase from a year earlier, with the FY2025 full-year figure at $108.3 million, up 25.07% from the prior year.
- Non-Current Deferred Tax Liability eased to $106.5 million in Q1 2026 per PHG's latest filing, from $108.3 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $116.3 million in Q2 2022 and bottomed at $73.0 million in Q2 2023.
- The 5-year median for Non-Current Deferred Tax Liability is $86.6 million (2024), against an average of $90.7 million.
- Across the five-year window, Non-Current Deferred Tax Liability soared 69.44% in 2022 and slumped 37.27% in 2023, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $92.8 million in 2022, then decreased by 17.72% to $76.4 million in 2023, then advanced by 13.31% to $86.6 million in 2024, then gained by 25.07% to $108.3 million in 2025, then fell by 1.59% to $106.5 million in 2026.
- Per Business Quant, the three latest PHG Non-Current Deferred Tax Liability figures stand at $106.5 million (Q1 2026), $108.3 million (Q4 2025), and $90.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.54 Mn |
| Mar 31, 2026 | 106.54 Mn |
| Dec 31, 2025 | 108.26 Mn |
| Dec 31, 2025 | 108.26 Mn |
| Sep 30, 2025 | 90.02 Mn |
| Sep 30, 2025 | 90.02 Mn |
| Jun 30, 2025 | 86.03 Mn |
| Jun 30, 2025 | 86.03 Mn |
| Mar 31, 2025 | 83.10 Mn |
| Mar 31, 2025 | 83.10 Mn |
| Dec 31, 2024 | 86.56 Mn |
| Dec 31, 2024 | 86.56 Mn |
| Jun 30, 2024 | 78.61 Mn |
| Jun 30, 2024 | 78.61 Mn |
| Dec 31, 2023 | 76.39 Mn |
| Dec 31, 2023 | 76.39 Mn |
| Jun 30, 2023 | 72.96 Mn |
| Jun 30, 2023 | 72.96 Mn |
| Dec 31, 2022 | 92.84 Mn |
| Dec 31, 2022 | 92.84 Mn |